FDA Gives Tentative Nod to $40 Generic HIV Prevention Shot for 120 Countries
The US Food and Drug Administration has tentatively approved a generic version of the twice-yearly lenacapavir injection, paving the way for a $40-a-year HIV prevention shot in 120 low- and middle-income countries.